0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Altretamine Market to Reach USD 210 Million by 2034, Driven by Rising Ovarian Cancer Cases and Advancements in Oncology TherapiesAccording to new market intelligence from Intel Market Research, the global Altretamine market was valued at USD 120 million in 2024, with projections indicating steady growth to USD 210 million by 2034 at a CAGR of 5.8% during the forecast period (2026-2034). This expansion reflects increasing adoption in oncology treatment protocols, particularly for platinum-resistant ovarian cancer cases,...0 Комментарии 0 Поделились 128 Просмотры 0 предпросмотр
-
Kirsten Rat Sarcoma (KRAS) Market: Targeted Therapies, Next-Generation Inhibitors (G12C), and Oncology Drug Development"Executive Summary Kirsten Rat Sarcoma (KRAS) Market Size and Share: Global Industry Snapshot Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market report offers the most appropriate solution for the...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Soft Tissue Sarcomas Treatment Market Driven by Advances in Targeted Oncology Therapies"Executive Summary Soft Tissue Sarcomas Treatment Market Trends: Share, Size, and Future Forecast CAGR Value The global Soft Tissue Sarcomas Treatment market size was valued at USD 1.52 billion in 2024 and is projected to reach USD 2.51 billion by 2032, with a CAGR of 6.49% during the forecast period of 2025 to 2032. Keeping into consideration the customer requirement, Soft Tissue...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Комментарии 0 Поделились 847 Просмотры 0 предпросмотр
-
Antiemetics Market Growth Addressing Nausea Management Across Oncology and Postoperative CareGlobal Demand Outlook for Executive Summary Antiemetics Market Size and Share CAGR Value The global antiemetics market size was valued at USD 39.68 billion in 2025 and is expected to reach USD 61.87 billion by 2033, at a CAGR of 5.71% during the forecast period The wide-ranging report deals with the new business challenges and investment research on Antiemetics Marketwhich includes...0 Комментарии 0 Поделились 725 Просмотры 0 предпросмотр
-
Global Somatostatin Analogs Market Poised for Steady Growth.The global somatostatin analogs market is experiencing robust growth, fueled by the increasing prevalence of hormonal disorders such as acromegaly and neuroendocrine tumors. These synthetic peptides mimic natural somatostatin, a hormone that inhibits the release of several other hormones, thus playing a crucial role in managing complex endocrine conditions. Market Drivers One of the...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
How Cancer Treatment Demand Is Expanding the Asia-Pacific Taxane MarketExecutive Summary Asia-Pacific Taxane Market Size and Share: Global Industry Snapshot CAGR Value Asia-Pacific taxane market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.7% in the forecast period of 2022 to 2029. The research and analysis carried out in this Asia-Pacific...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Расширенные страницы